NanoMaterials Technology Signs Exclusive Licensing Agreement for
Hyperlipidemia-controlling Drug with Beijing Winsunny
Pharmaceutical
2010-04-09 09:00
SINGAPORE, April 8 /PRNewswire-Asia/ --
NanoMaterials Technology Private Limited ("NMT") announced today
that it has signed an exclusive licensing agreement with Beijing
Winsunny Pharmaceutical Company Limited ("Winsunny Pharma") for the
use of its proprietary High Gravity Controlled Precipitation
("HGCP") Technology to manufacture, market and distribute a generic
version of a world-wide blockbuster hyperlipidemia-controlling drug
in China with a potential market size of over US$900 million.
Currently, there are 90 million patients in China undergoing
long-term treatment for hyperlipidemia. The annual growth rate of
the patients is about 15 million and it is estimated that the
number of patients required the treatment will reach 200 million in
the next 10 years.
Under the terms of the agreement, Winsunny
Pharma will pay an undisclosed upfront fee as well as milestones
and royalty payments based on future sales of the drug. NMT will
provide a new formulation that will increase efficacy, lower drug
dosage and provide better patient compliance. Winsunny Pharma will
assume all the costs of development, regulatory and
commercialization of the solid oral dosage formed drug including
clinical trials.
"Today's announcement is an important
milestone for NMT in deploying our HGCP technology in one of the
fastest growing and most important markets in the world for the
pharmaceutical sector," said Dr. Jimmy Yun, CEO of NMT.
"Previously, we had demonstrated the use of HGCP Technology in mass
production of specialty chemicals. This is our first collaboration
with Winsunny Pharma and it provides an opportunity to extend the
product range of their hyperlipidemia-controlling drugs. We believe
that this is the beginning of a series of drugs using our
technology to be made available in the market. We look forward to
having more collaboration with Winsunny Pharma in future."
"We have various late stage developments
which have the potential to reach commercialization in the near
future. Currently, we are in talks with pharmaceutical companies in
the US, Europe and China to commercialise several compounds using
HGCP technology," continued Dr. Yun.
The HGCP Technology allows production of
active pharmaceutical ingredient ("API") at both low micron and
nano-sized range. NMT has demonstrated the suitability of the
technology for processing APIs of both small and macro molecules to
be formulated for solid oral dosage and inhalation forms. The HGCP
Technology is also being used for designing drug particles with
good aerodynamic properties and specific particle size distribution
for pulmonary inhalation. It consolidates the current conventional
"crystallization, micronization and conditioning" manufacturing
processes into one-step, which is cost and time-saving.
About NanoMaterials Technology Pte Ltd
(http://www.nanomt.com)
Founded in April 2000, NanoMaterials
Technology (NMT) is a Singapore company that specialises in the
development and commercialisation of the production technologies of
nano-materials. NMT has a proprietary technology called the High
Gravity Controlled Precipitation (HGCP). The result of this
breakthrough is a nano-material production technology that is
simple, easy to scale up and extremely cost effective. The HGCP
Technology is versatile to be coupled with NMT's dispersion
technology and know how to improve the dispersibility of the
nano-particles.
About Beijing Winsunny Pharmaceutical Co.,
Ltd. (http://www.bjwsyy.com)
Founded in February 1999, Winsunny Pharma is
a pharmaceutical company in Beijing and is a subsidiary of Zhejiang
NHU Group (http://www.cnhu.com/en). Zhejiang NHU Group is a
public-listed company in Shenzhen Stock Exchange, China. Winsunny
Pharma specializes in hyperlipidemia-controlling, high blood
pressure, nephrology, CNS and diabetes drugs.
Contact Details:
NanoMaterials Technology Pte Ltd
Ms Grace Yeo
Tel: +65-6873-0735
Email: [email protected]
SOURCE NanoMaterials Technology Pte Ltd